ANI PHARMACEUTICALS, INC Senior Notes, Current
ANI PHARMACEUTICALS, INC (ANIP) had Senior Notes, Current of $8.17 million as of 2013-03-31, per its 10-Q filed 2013-05-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities › Notes Payable, Current
us-gaap:SeniorNotesCurrent · last filed 2013-05-10
- 2013-03-31: Senior Notes, Current $8.17M.
- 2012-12-31: Senior Notes, Current $7.88M.
- 2012-09-30: Senior Notes, Current $7.59M.
- 2012-06-30: Senior Notes, Current $10.48M.
| Period end | Senior Notes, Current |
|---|---|
| 2013-03-31 | $8.17M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $7.88M 10-Q · filed 2013-05-10 |
| 2012-09-30 | $7.59M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $10.48M 10-Q · filed 2012-08-01 |
| 2010-12-31 | $1.11M 8-K · filed 2013-01-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |